HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot.

Abstract
Our previous studies identified the extract of Beta vulgaris (beetroot), commercially also known as betanin, as a potent cancer chemopreventive agent in both in vitro Epstein-Barr early antigen activation assay and in an in vivo two-stage mouse lung and skin carcinogenesis. To explore this issue further, we have now investigated its cancer chemopreventive potentials in three different chemical carcinogen initiation-promotion experimental tumor models in mice. Following tumor initiation with 390 nmol of 7,12-dimethylbenz(a)anthracene (DMBA) in 100 microl of acetone, the mouse skin tumor promotion with 3430 J/m(2) of ultraviolet light-B (UV-B) as well as splenomegaly was significantly inhibited by oral administration of 0.0025% betanin. At the same dose, betanin also afforded significant protection in the mouse skin cancer model following the topical application of 390 nmol of (+/-)-(E)-4-methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3-hexanamide (NOR-1) in 100 microl of acetone and promoted by topical administration of 1.7 nmol of 12-O-tetradecanoylphorbol-13-acetate (TPA). In the two-stage model of hepatocarcinogenesis in mice with N-nitrosodiethylamine (DEN, 30 mg/kg) as the initiator and phenobarbital as the promoter, oral administration of 0.0025% betanin also showed a very significant inhibition of both the incidence and multiplicity of the liver tumors. These findings along with our initial reports suggest that betanin which is a regularly consumed natural product colorant is an effective cancer chemopreventive agent in mice. The most interesting observation is that the cancer chemopreventive effect was exhibited at a very low dose used in the study and thus indicating that beetroot warrants more attention for possible human applications in the control of malignancy.
AuthorsGovind J Kapadia, Magnus A Azuine, Rajagopalan Sridhar, Yoko Okuda, Atsushi Tsuruta, Eiichiro Ichiishi, Teruo Mukainake, Midori Takasaki, Takao Konoshima, Hoyoku Nishino, Harukuni Tokuda
JournalPharmacological research (Pharmacol Res) Vol. 47 Issue 2 Pg. 141-8 (Feb 2003) ISSN: 1043-6618 [Print] Netherlands
PMID12543062 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • (+-)-E-4-methyl-2-((E)-hydroxylamino)-5-nitro-6-methoxy-3-hexanamide
  • Anticarcinogenic Agents
  • Betacyanins
  • Carcinogens
  • Hydroxylamines
  • Indoles
  • Plant Extracts
  • Diethylnitrosamine
  • 9,10-Dimethyl-1,2-benzanthracene
  • betanin
  • Tetradecanoylphorbol Acetate
  • Phenobarbital
Topics
  • 9,10-Dimethyl-1,2-benzanthracene (antagonists & inhibitors, toxicity)
  • Animals
  • Anticarcinogenic Agents (pharmacology)
  • Beta vulgaris (chemistry)
  • Betacyanins
  • Body Weight (drug effects)
  • Carcinogens (antagonists & inhibitors, toxicity)
  • Diethylnitrosamine (antagonists & inhibitors, toxicity)
  • Dose-Response Relationship, Drug
  • Female
  • Hydroxylamines (antagonists & inhibitors, toxicity)
  • Indoles (pharmacology)
  • Liver Neoplasms, Experimental (chemically induced, prevention & control)
  • Mice
  • Mice, Inbred ICR
  • Neoplasms, Radiation-Induced (prevention & control)
  • Phenobarbital (antagonists & inhibitors, toxicity)
  • Plant Extracts (pharmacology)
  • Plant Roots (chemistry)
  • Skin Neoplasms (chemically induced, prevention & control)
  • Tetradecanoylphorbol Acetate (antagonists & inhibitors, toxicity)
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: